Wells Fargo & Company Lowers Molina Healthcare (NYSE:MOH) Price Target to $375.00

Molina Healthcare (NYSE:MOH - Free Report) had its price target decreased by Wells Fargo & Company from $410.00 to $375.00 in a research report released on Monday, Benzinga reports. Wells Fargo & Company currently has an equal weight rating on the stock.

Several other research firms also recently weighed in on MOH. Stephens restated an equal weight rating and set a $390.00 price objective on shares of Molina Healthcare in a report on Thursday. Cantor Fitzgerald reaffirmed an overweight rating and issued a $406.00 price target on shares of Molina Healthcare in a research report on Thursday, April 4th. Barclays decreased their price objective on Molina Healthcare from $437.00 to $430.00 and set an equal weight rating for the company in a report on Thursday. StockNews.com lowered Molina Healthcare from a strong-buy rating to a buy rating in a report on Thursday, February 8th. Finally, Bank of America downgraded Molina Healthcare from a neutral rating to an underperform rating and set a $439.00 price target for the company. in a report on Thursday, March 28th. One research analyst has rated the stock with a sell rating, four have given a hold rating and five have given a buy rating to the company's stock. According to MarketBeat, the company currently has an average rating of Hold and an average target price of $397.20.

Molina Healthcare Trading Up 0.5 %

Shares of Molina Healthcare stock traded up $1.76 during trading on Monday, hitting $343.99. The company's stock had a trading volume of 311,320 shares, compared to its average volume of 403,101. The stock has a market cap of $20.16 billion, a price-to-earnings ratio of 18.67, a price-to-earnings-growth ratio of 0.96 and a beta of 0.47. Molina Healthcare has a 52 week low of $266.35 and a 52 week high of $423.92. The stock has a 50-day moving average price of $390.34 and a two-hundred day moving average price of $372.35. The company has a debt-to-equity ratio of 0.53, a current ratio of 1.49 and a quick ratio of 1.49.

Molina Healthcare (NYSE:MOH - Get Free Report) last announced its quarterly earnings data on Wednesday, April 24th. The company reported $5.73 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $5.46 by $0.27. The company had revenue of $9.93 billion for the quarter, compared to the consensus estimate of $9.45 billion. Molina Healthcare had a return on equity of 29.86% and a net margin of 2.99%. The firm's revenue was up 21.9% compared to the same quarter last year. During the same period in the previous year, the business earned $5.81 EPS. Equities research analysts anticipate that Molina Healthcare will post 23.62 EPS for the current fiscal year.

Insiders Place Their Bets

In other Molina Healthcare news, CFO Mark Lowell Keim sold 15,000 shares of the company's stock in a transaction dated Monday, February 12th. The shares were sold at an average price of $386.56, for a total transaction of $5,798,400.00. Following the completion of the sale, the chief financial officer now directly owns 36,531 shares in the company, valued at $14,121,423.36. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. In related news, CFO Mark Lowell Keim sold 15,000 shares of Molina Healthcare stock in a transaction on Monday, February 12th. The shares were sold at an average price of $386.56, for a total value of $5,798,400.00. Following the transaction, the chief financial officer now directly owns 36,531 shares of the company's stock, valued at $14,121,423.36. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, Director Richard M. Schapiro sold 711 shares of the business's stock in a transaction dated Monday, February 12th. The shares were sold at an average price of $384.06, for a total transaction of $273,066.66. Following the completion of the transaction, the director now owns 12,207 shares in the company, valued at approximately $4,688,220.42. The disclosure for this sale can be found here. Insiders sold a total of 16,711 shares of company stock valued at $6,472,517 over the last quarter. 1.11% of the stock is owned by corporate insiders.

Institutional Investors Weigh In On Molina Healthcare

Several hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Clear Creek Financial Management LLC boosted its position in shares of Molina Healthcare by 2.2% in the 1st quarter. Clear Creek Financial Management LLC now owns 1,462 shares of the company's stock worth $601,000 after purchasing an additional 32 shares in the last quarter. Checchi Capital Advisers LLC bought a new position in shares of Molina Healthcare during the first quarter valued at $246,000. Lindbrook Capital LLC raised its position in shares of Molina Healthcare by 47.0% in the 1st quarter. Lindbrook Capital LLC now owns 322 shares of the company's stock worth $132,000 after purchasing an additional 103 shares during the last quarter. Fjarde AP Fonden Fourth Swedish National Pension Fund raised its position in shares of Molina Healthcare by 9.5% in the 1st quarter. Fjarde AP Fonden Fourth Swedish National Pension Fund now owns 10,400 shares of the company's stock worth $4,273,000 after purchasing an additional 900 shares during the last quarter. Finally, Valeo Financial Advisors LLC bought a new position in Molina Healthcare in the 1st quarter worth about $240,000. 98.50% of the stock is owned by hedge funds and other institutional investors.

About Molina Healthcare

Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.